Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.

BARD1 BRCA1 DNA damage response DNA end resection HDR histone homology-directed repair later stages for HDR completion substrates tumor suppression ubiquitin E3 ligase

Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
19 10 2023
Historique:
received: 21 03 2023
revised: 08 08 2023
accepted: 11 09 2023
pmc-release: 19 10 2024
medline: 26 10 2023
pubmed: 6 10 2023
entrez: 5 10 2023
Statut: ppublish

Résumé

The tumor-suppressor breast cancer 1 (BRCA1) in complex with BRCA1-associated really interesting new gene (RING) domain 1 (BARD1) is a RING-type ubiquitin E3 ligase that modifies nucleosomal histone and other substrates. The importance of BRCA1-BARD1 E3 activity in tumor suppression remains highly controversial, mainly stemming from studying mutant ligase-deficient BRCA1-BARD1 species that we show here still retain significant ligase activity. Using full-length BRCA1-BARD1, we establish robust BRCA1-BARD1-mediated ubiquitylation with specificity, uncover multiple modes of activity modulation, and construct a truly ligase-null variant and a variant specifically impaired in targeting nucleosomal histones. Cells expressing either of these BRCA1-BARD1 separation-of-function alleles are hypersensitive to DNA-damaging agents. Furthermore, we demonstrate that BRCA1-BARD1 ligase is not only required for DNA resection during homology-directed repair (HDR) but also contributes to later stages for HDR completion. Altogether, our findings reveal crucial, previously unrecognized roles of BRCA1-BARD1 ligase activity in genome repair via HDR, settle prior controversies regarding BRCA1-BARD1 ligase functions, and catalyze new efforts to uncover substrates related to tumor suppression.

Identifiants

pubmed: 37797621
pii: S1097-2765(23)00734-7
doi: 10.1016/j.molcel.2023.09.015
pmc: PMC10591799
mid: NIHMS1932878
pii:
doi:

Substances chimiques

Tumor Suppressor Proteins 0
BRCA1 Protein 0
Histones 0
Ubiquitin-Protein Ligases EC 2.3.2.27
DNA 9007-49-2
BARD1 protein, human EC 2.3.2.27
BRCA1 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3679-3691.e8

Subventions

Organisme : NCI NIH HHS
ID : R01 CA246807
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA268641
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA265315
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA244212
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA260834
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS106173
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM141091
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI136697
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of interests D.N.I. is a co-founder and a shareholder of E3 Bioscience LLC, a commercial entity that manufactures FRET-active E2∼Ub conjugates used in this study.

Références

PLoS One. 2020 Feb 24;15(2):e0229000
pubmed: 32092106
Cell Rep. 2014 Aug 21;8(4):999-1005
pubmed: 25131202
Nat Struct Biol. 2001 Oct;8(10):833-7
pubmed: 11573085
Cancer Cell. 2011 Dec 13;20(6):797-809
pubmed: 22172724
Science. 1999 Sep 3;285(5433):1576-9
pubmed: 10477523
Cancer Res. 2010 Feb 1;70(3):988-95
pubmed: 20103620
Methods Mol Biol. 2012;920:379-91
pubmed: 22941618
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5646-51
pubmed: 12732733
Nat Struct Mol Biol. 2007 Oct;14(10):941-8
pubmed: 17873885
Nature. 2017 Oct 19;550(7676):360-365
pubmed: 28976962
Nature. 2016 Jul 20;535(7612):382-7
pubmed: 27443740
Cold Spring Harb Protoc. 2015 Aug 03;2015(8):769-72
pubmed: 26240403
Mol Cell. 2006 Jun 23;22(6):719-729
pubmed: 16793542
Nat Commun. 2022 Nov 19;13(1):7104
pubmed: 36402777
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11364-9
pubmed: 10500182
Cell. 2001 Mar 9;104(5):743-53
pubmed: 11257228
Protein Sci. 2017 Mar;26(3):475-483
pubmed: 27977889
Am J Hum Genet. 2018 Oct 4;103(4):498-508
pubmed: 30219179
Cell. 1997 Jan 24;88(2):265-75
pubmed: 9008167
Nature. 2021 Aug;596(7872):433-437
pubmed: 34321663
Hum Mutat. 2001 Jun;17(6):520-1
pubmed: 11385711
Trends Biochem Sci. 2022 Jul;47(7):582-595
pubmed: 35351360
Annu Rev Biochem. 2019 Jun 20;88:221-245
pubmed: 30917004
Front Mol Biosci. 2019 Sep 03;6:79
pubmed: 31552267
Nat Struct Mol Biol. 2021 Mar;28(3):268-277
pubmed: 33589814
Hum Mutat. 2013 Mar;34(3):439-45
pubmed: 23161852
Nat Commun. 2015 Jul 07;6:7621
pubmed: 26151332
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20876-81
pubmed: 19088202
Mol Cell. 2014 May 8;54(3):445-59
pubmed: 24746700
Genes Dev. 2006 Jul 1;20(13):1721-6
pubmed: 16818604
J Cell Biol. 2012 Apr 16;197(2):201-8
pubmed: 22492723
Nucleic Acids Res. 2014 Jan;42(2):906-17
pubmed: 24150939
Mol Cell. 2015 Feb 19;57(4):636-647
pubmed: 25699710
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1110-5
pubmed: 15650050
Nat Genet. 1996 Dec;14(4):430-40
pubmed: 8944023
Methods Protoc. 2021 Dec 29;5(1):
pubmed: 35076555
Methods Mol Biol. 2015;1292:67-75
pubmed: 25804748
Cancer Cell. 2012 Jul 10;22(1):106-16
pubmed: 22789542
Methods Enzymol. 2018;600:25-66
pubmed: 29458761
Mol Cell. 1999 Oct;4(4):511-8
pubmed: 10549283
Nature. 2014 Oct 30;514(7524):591-6
pubmed: 25355358
Protein Expr Purif. 2015 Jun;110:89-94
pubmed: 25687285
Biochem J. 2021 Sep 30;478(18):3467-3483
pubmed: 34591954
Nat Protoc. 2006;1(1):23-9
pubmed: 17406208
Nature. 2018 Oct;562(7726):217-222
pubmed: 30209399
Nature. 2021 Aug;596(7872):438-443
pubmed: 34321665
Mol Cell. 2012 Sep 28;47(6):933-42
pubmed: 22885007
Science. 2011 Oct 28;334(6055):525-8
pubmed: 22034435
J Cell Biol. 2021 Apr 5;220(4):
pubmed: 33570569
Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18
pubmed: 24326623
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6086-91
pubmed: 11353843
Nat Rev Mol Cell Biol. 2020 May;21(5):284-299
pubmed: 32094664
Nucleic Acids Res. 2006 Mar 06;34(5):1416-26
pubmed: 16522651
Elife. 2017 Apr 11;6:
pubmed: 28398198
Genetics. 2015 Jun;200(2):413-22
pubmed: 25823446
Nat Commun. 2021 Aug 18;12(1):5016
pubmed: 34408138
Nat Cell Biol. 2019 Mar;21(3):311-318
pubmed: 30804502
Science. 1990 Dec 21;250(4988):1684-9
pubmed: 2270482
Cancer Discov. 2012 Aug;2(8):679-84
pubmed: 22843421
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5134-9
pubmed: 11320250
J Biol Chem. 2001 Mar 23;276(12):8798-806
pubmed: 11124265
Nature. 2014 Jun 26;510(7506):556-9
pubmed: 24776801
Nucleic Acids Res. 2015 Apr 30;43(8):4055-66
pubmed: 25820426
Mol Cell Biol. 2004 Nov;24(21):9478-86
pubmed: 15485915
Nat Struct Mol Biol. 2016 Jul;23(7):647-55
pubmed: 27239795

Auteurs

Meiling Wang (M)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Wenjing Li (W)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Nozomi Tomimatsu (N)

Department of Neurosurgery, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Corey H Yu (CH)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Jae-Hoon Ji (JH)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Salvador Alejo (S)

Department of Obstetrics & Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Samuel R Witus (SR)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

Dauren Alimbetov (D)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

O'Taveon Fitzgerald (O)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Bo Wu (B)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Qijing Wang (Q)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Yuxin Huang (Y)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Yaqi Gan (Y)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Felix Dong (F)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Youngho Kwon (Y)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Gangadhara R Sareddy (GR)

Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Tyler J Curiel (TJ)

Geisel School of Medicine at Dartmouth and Department of Medicine, Dartmouth Health, Lebanon, NH 03765, USA.

Amyn A Habib (AA)

Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Robert Hromas (R)

Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Carolina Dos Santos Passos (C)

Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, CO 80523, USA.

Tingting Yao (T)

Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, CO 80523, USA.

Dmitri N Ivanov (DN)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Peter S Brzovic (PS)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

Sandeep Burma (S)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Department of Neurosurgery, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. Electronic address: burma@uthscsa.edu.

Rachel E Klevit (RE)

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. Electronic address: klevit@uw.edu.

Weixing Zhao (W)

Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA; Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. Electronic address: zhaow2@uthscsa.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH